M. Baud

Oral second- and third-line lomustine–etoposide–cyclophosphamide chemotherapy for small cell lung cancer

B Lebeau, C. Chouaïd, M. Baud et al. · Lung Cancer · 2009 · 25 citations

Third-line Lomustine–etoposide–cyclophosphamide Chemotherapy, Oncology, Medicine +9

Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis

M. Baud, Salvatore Strano, Agnès Dechartres et al. · Journal of Thoracic and Cardiovascular Surgery · 2012 · 21 citations · Full text

Prognostic Factors, Neuro-oncology, Pleural Effusion +5

Primary Chordoma of the Lung

Salvatore Strano, Lamia Ouafi, M. Baud et al. · The Annals of Thoracic Surgery · 2009 · 18 citations

Multiple Pulmonary Nodule, Surgical Pathology, Histopathology +7

Routine once-weekly darbepoetin alfa administration is cost-effective in lung cancer patients with chemotherapy-induced anemia: A Markov analysis

Isabelle Borget, P. Tilleul, M. Baud et al. · Lung Cancer · 2006 · 16 citations

Markov Analysis, Medicine, Cancer Management +8

Economic implications of using pegfilgrastim rather than conventional G-CSF to prevent neutropenia during small-cell lung cancer chemotherapy

P. Tan Sean, C. Chouaïd, D. Hettler et al. · Current Medical Research and Opinion · 2009 · 15 citations